Global Anti-thrombogenic Coatings for Medical Devices Market Growth (Status and Outlook) 2026-2032
Description
The global Anti-thrombogenic Coatings for Medical Devices market size is predicted to grow from US$ 946 million in 2025 to US$ 1713 million in 2032; it is expected to grow at a CAGR of 9.0% from 2026 to 2032.
Anti-thrombogenic coatings for medical devices are specialized surface treatments applied to medical devices, such as catheters, stents, and heart valves, to prevent blood clot formation (thrombosis) upon contact with the device. These coatings are designed to mimic the natural properties of blood vessels, reducing the risk of clotting by inhibiting platelet adhesion and activation. Common materials used for anti-thrombogenic coatings include heparin, polyethylene glycol (PEG), and other bioactive compounds that interact with blood components to reduce clotting. By improving biocompatibility and reducing the need for anticoagulant therapies, these coatings enhance the safety and longevity of medical devices, particularly in long-term or high-risk applications.
United States market for Anti-thrombogenic Coatings for Medical Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Anti-thrombogenic Coatings for Medical Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Anti-thrombogenic Coatings for Medical Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Anti-thrombogenic Coatings for Medical Devices players cover WL Gore & Associates, Biointeractions, Toyobo, Surmodics, Corline Biomedical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Anti-thrombogenic Coatings for Medical Devices Industry Forecast” looks at past sales and reviews total world Anti-thrombogenic Coatings for Medical Devices sales in 2025, providing a comprehensive analysis by region and market sector of projected Anti-thrombogenic Coatings for Medical Devices sales for 2026 through 2032. With Anti-thrombogenic Coatings for Medical Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-thrombogenic Coatings for Medical Devices industry.
This Insight Report provides a comprehensive analysis of the global Anti-thrombogenic Coatings for Medical Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anti-thrombogenic Coatings for Medical Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-thrombogenic Coatings for Medical Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-thrombogenic Coatings for Medical Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-thrombogenic Coatings for Medical Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-thrombogenic Coatings for Medical Devices market by product type, application, key players and key regions and countries.
Segmentation by Type:
Active Anti-thrombogenic Coating
Inert Anti-thrombogenic Coating
Segmentation by Application:
Cardiovascular Devices
Catheters and Cannulas
Dialysis and Extracorporeal Circuits
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
WL Gore & Associates
Biointeractions
Toyobo
Surmodics
Corline Biomedical
jMedtech
Biosurf
Please note: The report will take approximately 2 business days to prepare and deliver.
Anti-thrombogenic coatings for medical devices are specialized surface treatments applied to medical devices, such as catheters, stents, and heart valves, to prevent blood clot formation (thrombosis) upon contact with the device. These coatings are designed to mimic the natural properties of blood vessels, reducing the risk of clotting by inhibiting platelet adhesion and activation. Common materials used for anti-thrombogenic coatings include heparin, polyethylene glycol (PEG), and other bioactive compounds that interact with blood components to reduce clotting. By improving biocompatibility and reducing the need for anticoagulant therapies, these coatings enhance the safety and longevity of medical devices, particularly in long-term or high-risk applications.
United States market for Anti-thrombogenic Coatings for Medical Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Anti-thrombogenic Coatings for Medical Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Anti-thrombogenic Coatings for Medical Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Anti-thrombogenic Coatings for Medical Devices players cover WL Gore & Associates, Biointeractions, Toyobo, Surmodics, Corline Biomedical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Anti-thrombogenic Coatings for Medical Devices Industry Forecast” looks at past sales and reviews total world Anti-thrombogenic Coatings for Medical Devices sales in 2025, providing a comprehensive analysis by region and market sector of projected Anti-thrombogenic Coatings for Medical Devices sales for 2026 through 2032. With Anti-thrombogenic Coatings for Medical Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-thrombogenic Coatings for Medical Devices industry.
This Insight Report provides a comprehensive analysis of the global Anti-thrombogenic Coatings for Medical Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anti-thrombogenic Coatings for Medical Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-thrombogenic Coatings for Medical Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-thrombogenic Coatings for Medical Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-thrombogenic Coatings for Medical Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-thrombogenic Coatings for Medical Devices market by product type, application, key players and key regions and countries.
Segmentation by Type:
Active Anti-thrombogenic Coating
Inert Anti-thrombogenic Coating
Segmentation by Application:
Cardiovascular Devices
Catheters and Cannulas
Dialysis and Extracorporeal Circuits
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
WL Gore & Associates
Biointeractions
Toyobo
Surmodics
Corline Biomedical
jMedtech
Biosurf
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
87 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Anti-thrombogenic Coatings for Medical Devices Market Size by Player
- 4 Anti-thrombogenic Coatings for Medical Devices by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Anti-thrombogenic Coatings for Medical Devices Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
